| 前收盘价格 | 75.11 |
| 收盘价格 | 75.58 |
| 成交量 | 2,092,647 |
| 平均成交量 (3个月) | 2,020,360 |
| 市值 | 37,134,385,152 |
| 市盈率 (P/E TTM) | 34.77 |
| 预期市盈率 (P/E Forward) | 20.96 |
| 价格/销量 (P/S) | 3.73 |
| 股市价格/股市净资产 (P/B) | 1.68 |
| 52周波幅 | |
| 利润日期 | 11 Nov 2025 |
| 股息率 (DY TTM) | 0.35% |
| 营业毛利率 | 11.28% |
| 营业利益率 (TTM) | 13.30% |
| 稀释每股收益 (EPS TTM) | 2.25 |
| 季度收入增长率 (YOY) | 0.60% |
| 季度盈利增长率 (YOY) | 41.10% |
| 总债务/股东权益 (D/E MRQ) | 23.63% |
| 流动比率 (MRQ) | 2.70 |
| 营业现金流 (OCF TTM) | 2.12 B |
| 杠杆自由现金流 (LFCF TTM) | 1.18 B |
| 资产报酬率 (ROA TTM) | 2.74% |
| 股东权益报酬率 (ROE TTM) | 5.23% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | Alcon Inc. | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 5.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 2.00 |
|
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Large Core |
| 内部持股比例 | 0.13% |
| 机构持股比例 | 68.26% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Zurcher Kantonalbank (Zurich Cantonalbank) | 30 Jun 2025 | 9,142,139 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 110.00 (Mizuho, 46.45%) | 购买 |
| 中 | 91.00 (21.16%) | |
| 低 | 77.53 (JP Morgan, 3.22%) | 保留 |
| 平均值 | 91.61 (21.97%) | |
| 总计 | 5 购买, 4 保留 | |
| 平均价格@调整类型 | 77.91 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 13 Oct 2025 | 91.00 (21.16%) | 购买 | 72.60 |
| Barclays | 13 Oct 2025 | 86.00 (14.50%) | 保留 | 72.60 |
| Stifel | 29 Sep 2025 | 85.00 (13.17%) | 购买 | 74.11 |
| 21 Aug 2025 | 90.00 (19.82%) | 购买 | 79.18 | |
| Baird | 21 Aug 2025 | 95.00 (26.48%) | 购买 | 79.18 |
| JP Morgan | 21 Aug 2025 | 77.53 (3.22%) | 保留 | 79.18 |
| Mizuho | 21 Aug 2025 | 110.00 (46.45%) | 购买 | 79.18 |
| Morgan Stanley | 21 Aug 2025 | 80.00 (6.51%) | 保留 | 79.18 |
| Needham | 20 Aug 2025 | 107.00 (42.46%) | 购买 | 81.04 |
| 13 Aug 2025 | 107.00 (42.46%) | 购买 | 86.48 | |
| Wells Fargo | 06 Aug 2025 | 93.00 (23.82%) | 保留 | 84.12 |
| 显示更多 | ||||
该时间范围内无数据。
| 股息率 (DY TTM) | 0.35% |
| 4年平均股息收益率 | 0.26% |
| 股息支付比率 | 11.81% |
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 14 May 2024 | 08 Apr 2024 | 16 May 2024 | 0.2644 现金 |
| 10 May 2023 | 30 Mar 2023 | 12 May 2023 | 0.2356 现金 |
| 29 Apr 2022 | 24 Mar 2022 | 05 May 2022 | 0.2083 现金 |
| 04 May 2021 | 24 Mar 2021 | 06 May 2021 | 0.0909 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2024 | 0.264 | 1 | 0.31 |
| 2023 | 0.236 | 1 | 0.30 |
| 2022 | 0.208 | 1 | 0.30 |
| 2021 | 0.091 | 1 | 0.10 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合